Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease

被引：0
|
作者：
Miller, Paul D. [1 ]
Yu, Zhigang [2 ]
机构：
[1] Colorado Ctr Bone Hlth, Lakewood, CO 80232 USA
[2] Amgen Inc, Thousand Oaks, CA USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2023年 / 38卷 / 02期
关键词：
D O I：
10.1002/jbmr.4761
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF ROMOSOZUMAB AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND MILD-TO-MODERATE CHRONIC KIDNEY DISEASE
    Miller, D.
    Adachi, J.
    Albergaria, B. -H.
    Cheung, A. M.
    Chines, A.
    Gielen, E.
    Langdahl, B.
    Miyauchi, A.
    Oates, M.
    Reid, I. R.
    Santiago, N. Ruiz
    Vanderkelen, M.
    Yang, W.
    Yu, Z.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S41 - S41
  • [2] Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease
    Miller, Paul D.
    Adachi, Jonathan D.
    Albergaria, Ben-Hur
    Cheung, Angela M.
    Chines, Arkadi A.
    Gielen, Evelien
    Langdahl, Bente L.
    Miyauchi, Akimitsu
    Oates, Mary
    Reid, Ian R.
    Santiago, Norma Ruiz
    Vanderkelen, Mark
    Wang, Zhenxun
    Yu, Zhigang
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (08) : 1437 - 1445
  • [3] EFFICACY AND SAFETY OF ROMOSOZUMAB AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND MILD-TO-MODERATE CHRONIC KIDNEY DISEASE
    Miller, P.
    Adachi, J.
    Albergaria, B. H.
    Cheung, A. M.
    Chines, A.
    Gielen, E.
    Langdahl, B.
    Miyauchi, A.
    Oates, M.
    Reid, I.
    Santiago, N. Ruiz
    Vanderkelen, M.
    Yang, W.
    Yu, Z.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 185 - 185
  • [4] Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease
    Miyauchi, Akimitsu
    Hamaya, Etsuro
    Nishi, Kiyoshi
    Tolman, Cae
    Shimauchi, Junichiro
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2022, 40 (04) : 677 - 687
  • [5] Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease
    Akimitsu Miyauchi
    Etsuro Hamaya
    Kiyoshi Nishi
    Cae Tolman
    Junichiro Shimauchi
    [J]. Journal of Bone and Mineral Metabolism, 2022, 40 : 677 - 687
  • [6] Efficacy and Safety of Romosozumab vs Placebo Among Patients with Mild-to-Moderate Chronic Kidney Disease
    Miller, Paul
    Chines, Arkadi
    Albergaria, Ben-Hur
    Gielen, Evelien
    Langdahl, Bente
    Miyauchi, Akimitsu
    Vanderkelen, Mark
    Milmont, Cassandra
    Maddox, Judy
    Adachi, Jonathan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [7] Efficacy and Safety of Romosozumab vs Placebo Among Patients With Mild-to-Moderate Chronic Kidney Disease (CKD)
    Miller, Paul
    Chines, Arkadi
    Milmont, Cassandra E.
    Maddox, Judy
    Albergaria, Ben-Hur
    Gielen, Evelien
    Langdahl, Bente
    Miyauchi, Akimitsu
    Vanderkelen, Mark
    Adachi, Jonathan
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 30 - 30
  • [8] Safety and Efficacy of Denosumab Among Subjects in the FREEDOM Extension Study With Mild-to-Moderate Chronic Kidney Disease (CKD).
    Broadwell, Aaron
    Ebeling, Peter R.
    Franek, Edward
    Goemaere, Stefan
    Wagman, Rachel B.
    Yin, Xiang
    Yue, Susan
    Miller, Paul D.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S24 - S24
  • [9] Safety and efficacy of denosumab among subjects in the FREEDOM extension study with mild-to-moderate chronic kidney disease (CKD)
    Broadwell, A.
    Ebeling, P.
    Franek, E.
    Goemaere, S.
    Wagman, R.
    Yin, X.
    Yue, S.
    Miller, P.
    [J]. AUSTRALASIAN JOURNAL ON AGEING, 2018, 37 : 76 - 76
  • [10] Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease
    Adami, Giovanni
    Gatti, Davide
    Fassio, Angelo
    Viapiana, Ombretta
    Rossini, Maurizio
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 (02) : 354 - 355
12345